SCHEMBL17078529

SCHEMBL17078529

CCCCN1C[C@@H](C)N(Cc2ccc(C(=O)OC)cc2)[C@@H](C)C1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ CHKA P35790 1/20 0.46
▸ LMNA P02545 1/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ GRM2 Q14416 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ CYP4A11 Q02928 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17078460 0.90 KDM4E (0.50) KDM4EMEN1KMT2AALDH1A1HDAC1
SCHEMBL20420948 0.86 S1PR5 (0.46) KDM4EMEN1KMT2AALDH1A1HDAC1
SCHEMBL17078819 0.85 HDAC6 (0.62) HDAC1HDAC6
SCHEMBL17078512 0.85 LMNA (0.56) KDM4EMEN1KMT2AALDH1A1HTT
SCHEMBL20433103 0.85 HDAC6 (0.62) HDAC1HDAC6
SCHEMBL17078766 0.85 KDM4E (0.52) KDM4EMEN1KMT2AALDH1A1HDAC1
SCHEMBL17078701 0.83 OPRM1 (0.49) MEN1KMT2AALDH1A1HDAC1HDAC6
SCHEMBL17078589 0.83 OPRM1 (0.49) MEN1KMT2AALDH1A1HDAC1HDAC6
SCHEMBL17086785 0.82 HDAC1 (0.58) KDM4EMEN1KMT2AALDH1A1HDAC1
SCHEMBL17078776 0.82 HDAC1 (0.58) KDM4EMEN1KMT2AALDH1A1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2019-05-14 — — US disclosed
EP-3116859-B1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2018-08-01 — — EP disclosed
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-04-06 — — US disclosed
EP-3116859-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2017-01-18 — — EP disclosed
WO-2015137750-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same HDAC6, HDAC1, HDAC11 KDM4E 319/4885MEN1 2537/4885KMT2A 43/4885
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME HDAC6, HDAC1, HDAC5 KDM4E 468/4885MEN1 3278/4885KMT2A 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback